Bristol-Myers CEO Says Celgene Purchase Not a ‘Defensive’ Move

Bookmark
(Bloomberg) -- Bristol-Myers Squibb Co.’s chief executive officer said that while the drugmaker had talked with other companies about possible deals, none of those conversations got serious enough ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.